Skip to main content

ConvergEx Enhances NorthPoint Offering

Clients of prime-services provider NorthPoint Trading Partners will now have access to Eze Castle Software's portfolio analytics and risk tools. Eze Castle Software is a subsidiary of BNY ConvergEx.

The new offering will allow NorthPoint's clients to view all of their intraday positions across all asset classes, even if they use multiple clearing firms. They can also dive down and examine the positions by sector, industry, asset attribution, delta and delta-adjusted exposure, and by highest and

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@waterstechnology.com or view our subscription options here: https://subscriptions.waterstechnology.com/subscribe

You are currently unable to copy this content. Please contact info@waterstechnology.com to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Waterstechnology? View our subscription options

‘Vibe coding is burning us out’

Vibe coding is rapidly spreading throughout the capital markets, and some are unhappy about it, while others believe the genie is out of the bottle. Engineers spoken to for this story share some choice words—and several expletives—about this new form of coding.

DTCC dives into public cloud

The clearing house has begun migrating its equities clearing and settlement systems to AWS, while its tokenization systems have migrated to Microsoft Azure ahead of their launch this fall.

Solving the last line of latency

Repurposed copper cables and hollow-core fiber can optimize latency even for firms who feel they’ve hit a ceiling, writes Vahan Sardaryan in this guest column.

Most read articles loading...

You need to sign in to use this feature. If you don’t have a WatersTechnology account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here